Nuplazid 34 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DB25FJVKZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,459
Award facts
- Contract value 100% obligated
- $3,458.51 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $3,458.51 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules in quantities of 30. The award was issued on September 11, 2025, with an ultimate completion date of October 2, 2025, and carries no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA's SPE2DB program, valued at approximately $500 million through November 2026, which authorizes the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its woman-owned small business status to secure and maintain substantial contract volumes with the Department of Defense healthcare system. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to military and federal healthcare facilities nationwide. Nuplazid, an antipsychotic medication used primarily in the treatment of Parkinson's disease psychosis, represents one of many specialty pharmaceutical products the contractor delivers through its consolidated DLA contract vehicle, enabling efficient procurement and distribution of essential medications to military health facilities globally.
Quick answers
Who was awarded contract SPE2DB25FJVKZ?
SPE2DB25FJVKZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FJVKZ worth?
The government has obligated $3,459 on SPE2DB25FJVKZ.
Is contract SPE2DB25FJVKZ an order under another contract?
Yes. SPE2DB25FJVKZ is a delivery order under SPE2DB24D9250, an indefinite delivery contract.
Was contract SPE2DB25FJVKZ competed?
The extent of competition for SPE2DB25FJVKZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award